Professor Alessandro Cataliotti
Oslo University Hospital Rikshospitalet, Oslo (Norway)
ProANP31-67 ameliorates adverse cardiac remodeling and improves systolic and diastolic functions in a preclinical model of cardiorenal syndrome
Event: Frontiers in CardioVascular Biomedicine 2022
Topic: Drugs, Drug Targets
Session: Moderated poster 9 - Drugs
ESC 365 is supported by
